https://orthotw.com/2026/10/when-more-expensive-doesn-t-mean-better-the-acdf-markup-mysteryOrthopedics This Weeken2026-10-01T00:06:00.000ZWhen More Expensive Doesn’t Mean Better: The ACDF Markup Mystery https://orthotw.com/2026/09/it-s-not-just-what-you-lift-it-s-what-you-do-while-you-lift-itOrthopedics This Weeken2026-09-30T23:59:00.000ZIt’s Not Just What You Lift – It’s What You Do While You Lift It https://orthotw.com/2026/09/xtant-a-smaller-top-line-a-bigger-cash-questionOrthopedics This Weeken2026-09-30T14:22:00.000ZXtant: A Smaller Top Line, a Bigger Cash Question https://orthotw.com/2026/09/bioventus-the-tax-line-steals-the-showOrthopedics This Weeken2026-09-30T14:09:00.000ZBioventus: The Tax Line Steals the Show https://orthotw.com/2026/09/difusion-activates-operating-board-to-scale-therapeutic-biomaterials-platformOrthopedics This Weeken2026-09-30T12:14:00.000ZDiFusion Activates Operating Board to Scale Therapeutic Biomaterials Platform https://orthotw.com/2026/09/xenix-medical-announces-fda-clearance-of-nanoactiv-surface-technology-for-its-riva-posterior-fixation-systemOrthopedics This Weeken2026-09-30T11:31:00.000ZXenix Medical Announces FDA Clearance of NanoACTIV™ Surface Technology for Its Riva® Posterior Fixation System https://orthotw.com/2026/09/fibrobiologics-announces-grant-of-european-patent-for-methods-of-enhancing-fibroblast-therapeutic-activityOrthopedics This Weeken2026-09-29T18:48:00.000ZFibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity https://orthotw.com/2026/09/vb-spine-announces-fda-breakthrough-device-designation-for-new-blood-test-designed-to-identify-patients-at-risk-for-scoliosis-progressionOrthopedics This Weeken2026-09-29T13:05:00.000ZVB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression https://orthotw.com/2026/09/aclarion-welcomes-nyu-langone-health-to-clarity-trial-network-now-enrolling-at-eleven-sitesOrthopedics This Weeken2026-09-29T12:58:00.000ZAclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites https://orthotw.com/2026/09/si-bone-receives-fda-510-k-clearance-for-ifuse-granite-onyx-extending-its-compromised-bone-franchise-beyond-the-pelvis-fda-breakthrough-device-designated-bdd-platform-engineered-for-durable-fixation-in-low-density-boneOrthopedics This Weeken2026-09-29T12:40:00.000ZSI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis FDA Breakthrough Device Designated (BDD) platform engineered for durable fixation in low density bone https://orthotw.com/2026/09/avesi-partners-announces-investment-in-new-age-medicalOrthopedics This Weeken2026-09-29T12:23:00.000ZAvesi Partners Announces Investment in New Age Medical https://orthotw.com/2026/09/difusion-to-define-therapeutic-biomaterials-category-at-nass-2026Orthopedics This Weeken2026-09-29T12:00:00.000ZDiFusion to Define Therapeutic Biomaterials Category at NASS 2026 https://orthotw.com/2026/09/bracing-for-prison-dme-owner-gets-13-months-in-medicare-kickback-caseOrthopedics This Weeken2026-09-29T11:58:00.000ZBracing for Prison: DME Owner Gets 13 Months in Medicare Kickback Case https://orthotw.com/2026/09/stryker-strong-growth-with-a-tariff-tailwind-in-the-profit-lineOrthopedics This Weeken2026-09-29T11:40:00.000ZStryker: Strong Growth, With a Tariff Tailwind in the Profit Line